发明名称 GENE THERAPY TO PROMOTE ANGIOGENESIS
摘要 Angiogenesis is a complex biological phenomenon. Various signals and compoun ds have been shown to influence angiogenesis in vivo. Patients suffering from endothelial dysfunction often produce substantial amounts of the angiogenic factors such as bFGF and VEGF but still novel angiogenesis in these patients is not observed or insufficient. In the present invention it has been found that nitric oxide is capable of enhancing angiogenesis in endothelial dysfuncion. The present invention provides a nulceic acid delivery vehicle f or enhancing and/or inducing angiogenesis, comprising a nucleic acid comprising at least one sequence coding for a protein capable of increasing nitric oxid e production, and further comprising a nucleic delivery carrier.
申请公布号 CA2358014(A1) 申请公布日期 2000.07.13
申请号 CA19992358014 申请日期 1999.12.27
申请人 CRUCELL HOLLAND B.V. 发明人 VAN ZONNEVELD, ANTON JAN;VERLINDEN, STEFAN FREDERIK FRANCISCUS
分类号 A61K38/18;A61K38/19;A61K38/44;A61K48/00;A61P43/00;C12N5/10;C12N9/02;C12N15/53;C12N15/861;(IPC1-7):C12N15/86;C12N15/59 主分类号 A61K38/18
代理机构 代理人
主权项
地址